Literature DB >> 28065245

Research Advances in the Mechanisms of Gastric Cancer Multidrug Resistance.

Hao Huang1, Xing-Jiu Yang1, Ran Gao1.   

Abstract

Gastric cancer is one of the most common human malignancies and the third cause of death from cancer in China and worldwide. Chemotherapy is still one of the major treatment options for advanced gastric cancer. However,the efficacy of chemotherapy for gastric cancer remains poor due to its insensitivity and the development of multidrug resistance (MDR). While many molecules and mechanisms have been found to be associated with the development of gastric cancer MDR,the specific mechanisms remains unclear. In our current article,we reviews the identification of MDR-related molecules and mechanisms,with an attempt to a better understand the specific mechanisms of gastric cancer MDR and thus provide new insights into the fight against gastric cancer MDR.

Entities:  

Mesh:

Year:  2016        PMID: 28065245     DOI: 10.3881/j.issn.1000-503X.2016.06.020

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  2 in total

1.  Ghrelin Affects Gastric Cancer Progression by Activating AMPK Signaling Pathway.

Authors:  Xiao-Lin Hu; Yong-Jun Zhu; Chang-Hua Hu; Li You; Juan Wu; Xiao-Yan He; Wen-Jie Huang; Zong-Hui Wu
Journal:  Biochem Genet       Date:  2021-01-13       Impact factor: 1.890

2.  Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.

Authors:  Wenjie Huang; Huijuan Tang; Fang Wen; Xiaona Lu; Qingpei Li; Peng Shu
Journal:  BMC Complement Med Ther       Date:  2020-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.